Pulmonary Disease Doctors in Ridley Park, PA Accepting Medicare

3 Pulmonary Disease doctors found. Showing 1 - 3

Dr. Gerald Anthony Meis, D.O Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Bartol Ave, Ste 14, Ridley Park, PA 19078 Phone: 610-521-1300    Fax: 610-521-9074

Dr. Daniel Christopher Dupont, D.O Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Bartol Ave, Ste 14, Ridley Park, PA 19078 Phone: 610-521-1300    Fax: 610-521-9074

Dr. Eric Scott Heffelfinger, D.O Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Bartol Ave, Ste 14, Ridley Park, PA 19078 Phone: 610-521-1300    Fax: 610-521-9074

News Archive

Sequenom CMM, CombiMatrix sign collaboration agreement to market CMA testing for NIPT

Sequenom, Inc., a life sciences company providing innovative diagnostic testing and genetic analysis solutions, and CombiMatrix Corporation, a molecular diagnostics laboratory performing DNA-based testing services for developmental disorders and cancer, today jointly announced that the Sequenom Center for Molecular Medicine LLC and CombiMatrix have entered into a collaboration agreement to market chromosomal microarray analysis testing services to broaden and confirm the results of noninvasive, prenatal testing to physicians and their patients.

Susceptibility to vCJD was predicted to increase during childhood, peak during adolescence and decrease sharply afterwards

That young people tend to eat more beef products is not enough to explain the strikingly high proportion of new-variant Creutzfeldt-Jacob disease cases among children and adolescents. An article published this week in BMC Infectious Diseases, shows that young people must also be more susceptible to vCJD infection because of their age.

Tomato juice may help type 2 diabetics

Tomato juice may be the key to decreasing hyperactive platelet aggregation, which can lead to heart disease, according to the latest nutrition and dietetics study by HMRI researchers based at the University of Newcastle.

PK molecule could be a target for vascular complications linked to type 1 diabetes

In an article published ahead of print on November 24, 2015 in the journal Diabetes (available at http://dx.doi.org/10.2337/db15-0930), researchers from the Medical University of South Carolina, the American University of Beirut, and Case Western Reserve University report that a molecule called pre-kallikrein (PK) could be a target for the vascular complications associated with type 1 diabetes.

Read more Medical News

› Verified 9 days ago